BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

281 related articles for article (PubMed ID: 29802710)

  • 21. Keratin 17 Promotes Lung Adenocarcinoma Progression by Enhancing Cell Proliferation and Invasion.
    Liu J; Liu L; Cao L; Wen Q
    Med Sci Monit; 2018 Jul; 24():4782-4790. PubMed ID: 29991674
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Aberrant expression of deubiquitylating enzyme USP9X predicts poor prognosis in gastric cancer.
    Fu X; Xie W; Song X; Wu K; Xiao L; Liu Y; Zhang L
    Clin Res Hepatol Gastroenterol; 2017 Dec; 41(6):687-692. PubMed ID: 28274596
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Up-regulation of long non-coding RNA PCAT-1 correlates with tumor progression and poor prognosis in gastric cancer.
    Cui WC; Wu YF; Qu HM
    Eur Rev Med Pharmacol Sci; 2017 Jul; 21(13):3021-3027. PubMed ID: 28742205
    [TBL] [Abstract][Full Text] [Related]  

  • 24. High mobility group-box 3 overexpression is associated with poor prognosis of resected gastric adenocarcinoma.
    Tang HR; Luo XQ; Xu G; Wang Y; Feng ZJ; Xu H; Shi YW; Zhang Q; Wu LG; Xue CQ; Wang CW; Wu CY
    World J Gastroenterol; 2012 Dec; 18(48):7319-26. PubMed ID: 23326140
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Expressions of Slug, ZEB1 and KISS-1 in gastric adenocarcinoma and their clinical significance].
    Zhou L; Hu YL; Wu SW; Yu L; Cheng ZN; Zhu B
    Nan Fang Yi Ke Da Xue Xue Bao; 2016 Apr; 36(4):532-7. PubMed ID: 27113182
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Decreased expression of SCUBE2 is associated with progression and prognosis in colorectal cancer.
    Song Q; Li C; Feng X; Yu A; Tang H; Peng Z; Wang X
    Oncol Rep; 2015 Apr; 33(4):1956-64. PubMed ID: 25672935
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Lin28B is a novel prognostic marker in gastric adenocarcinoma.
    Hu Q; Peng J; Liu W; He X; Cui L; Chen X; Yang M; Liu H; Liu S; Wang H
    Int J Clin Exp Pathol; 2014; 7(8):5083-92. PubMed ID: 25197381
    [TBL] [Abstract][Full Text] [Related]  

  • 28. DIMT1 overexpression correlates with progression and prognosis in gastric carcinoma.
    Liu G; Peng X; Cai Y; Cheng A; Zha L; Wang Z
    Hum Pathol; 2017 Dec; 70():35-42. PubMed ID: 28601661
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Relationship between expression of IGFBP7 and clinicopathological variables in gastric cancer.
    Sato Y; Inokuchi M; Takagi Y; Otsuki S; Fujimori Y; Yanaka Y; Kobayashi K; Higuchi K; Kojima K; Kawano T
    J Clin Pathol; 2015 Oct; 68(10):795-801. PubMed ID: 26043748
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Expression of ribophorine II is a promising prognostic factor in human gastric adenocarcinoma.
    Fujimoto D; Goi T; Hirono Y
    Int J Oncol; 2017 Feb; 50(2):448-456. PubMed ID: 28035352
    [TBL] [Abstract][Full Text] [Related]  

  • 31. USP33, a new player in lung cancer, mediates Slit-Robo signaling.
    Wen P; Kong R; Liu J; Zhu L; Chen X; Li X; Nie Y; Wu K; Wu JY
    Protein Cell; 2014 Sep; 5(9):704-13. PubMed ID: 24981056
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Low CA II expression is associated with tumor aggressiveness and poor prognosis in gastric cancer patients.
    Hu X; Huang Z; Liao Z; He C; Fang X
    Int J Clin Exp Pathol; 2014; 7(10):6716-24. PubMed ID: 25400751
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Long non-coding RNA CCAT2 is up-regulated in gastric cancer and associated with poor prognosis.
    Wang CY; Hua L; Yao KH; Chen JT; Zhang JJ; Hu JH
    Int J Clin Exp Pathol; 2015; 8(1):779-85. PubMed ID: 25755774
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Decreased expression of SEMA3A is associated with poor prognosis in gastric carcinoma.
    Tang C; Gao X; Liu H; Jiang T; Zhai X
    Int J Clin Exp Pathol; 2014; 7(8):4782-94. PubMed ID: 25197349
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Nedd4-1 is an exceptional prognostic biomarker for gastric cardia adenocarcinoma and functionally associated with metastasis.
    Sun A; Yu G; Dou X; Yan X; Yang W; Lin Q
    Mol Cancer; 2014 Nov; 13():248. PubMed ID: 25395181
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Elevated JMJD1A is a novel predictor for prognosis and a potential therapeutic target for gastric cancer.
    Yang H; Liu Z; Yuan C; Zhao Y; Wang L; Hu J; Xie D; Wang L; Chen D
    Int J Clin Exp Pathol; 2015; 8(9):11092-9. PubMed ID: 26617828
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Long non‑coding RNA RP1‑163G9.1 is downregulated in gastric adenocarcinoma and is associated with a poor prognosis.
    Sun B; Dang Y; Zhang F; Li K; Ouyang X; Wang K; Huang Q
    Oncol Rep; 2019 Jun; 41(6):3575-3585. PubMed ID: 31002370
    [TBL] [Abstract][Full Text] [Related]  

  • 38. LETM1 is a potential biomarker that predicts poor prognosis in gastric adenocarcinoma.
    Li H; Piao L; Xu D; Xuan Y
    Exp Mol Pathol; 2020 Feb; 112():104333. PubMed ID: 31705880
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Silencing profilin-1 inhibits gastric cancer progression via integrin β1/focal adhesion kinase pathway modulation.
    Cheng YJ; Zhu ZX; Zhou JS; Hu ZQ; Zhang JP; Cai QP; Wang LH
    World J Gastroenterol; 2015 Feb; 21(8):2323-35. PubMed ID: 25741138
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Linc00675 is a novel marker of short survival and recurrence in patients with pancreatic ductal adenocarcinoma.
    Li DD; Fu ZQ; Lin Q; Zhou Y; Zhou QB; Li ZH; Tan LP; Chen RF; Liu YM
    World J Gastroenterol; 2015 Aug; 21(31):9348-57. PubMed ID: 26309360
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.